
Lorundrostat cut systolic BP by 9.6 mm Hg and UACR by 52.2% vs placebo in participants with CKD and uncontrolled hypertension in Launch-HTN.
Multislice computed tomography (MSCT) detects proximal coronary atherosclerotic plaque or obstructive coronary artery disease (CAD) in "a significant proportion" of patients with a low or intermediate Framingham risk score, according to research conducted at the Cleveland Clinic in Ohio.






